COMP <GO>
TLRY vs TRLV // EV/EBITDA & P/E VALUATION
Tilray Brands Inc. (NASDAQ) VS. Trulieve Cannabis Corp. Subordinate Voting Shares (NYSE) • 15-METRIC TALLY: TLRY 1
— TRLV 9
■ METRIC PARITY
LAST: $2.64 (-1.86%) • MKT CAP: $390.2M
valuation
—
LAST: $10.60 (-0.19%) • MKT CAP: $2.04B
valuation
9.9x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TLRY VS. TRLV)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | TLRY | TRLV | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 28.40% | 60.20% | -31.80 | TRLV | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -3.90% | 12.80% | -16.70 | TRLV | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | 9.9x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -17.72% | 11.20% | -28.92 | TRLV | /fcf-yield <GO> |
| Operating Margin | -6.90% | 12.10% | -19.00 | TRLV | /operating-margins <GO> |
| Net Profit Margin | -13.30% | -9.90% | -3.40 | TRLV | /net-margins <GO> |
| Revenue Growth (YoY) | 11.50% | -0.40% | +11.90 | TLRY | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 1.12 | -0.92 | TRLV | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 6/9 | -1.00 | TRLV | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 18.4 | 43.3 | -24.84 | TRLV | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $390.2M | $2.04B | -$1.65B | TRLV | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | TLRY REV | TRLV REV | TLRY GROSS % | TRLV GROSS % | TLRY FCF | TRLV FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $915.5M | $1.18B | 28.4% | 60.2% | -$69.1M | $228.6M |
| FY 2024 | $821.3M | $1.19B | 29.3% | 60.3% | -$94.6M | $148.9M |
| FY 2023 | $788.9M | $1.13B | — | — | -$30.9M | $201.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TLRY // BETA —
TRLV // BETA —